GALMED PHARMACEUTICALS LTD NASDAQ:GLMD Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.

Location: Tel Aviv Yafo, 6578317, Israel | Website: galmedpharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing